Archives
-
Deep Learning of USC Mitochondria in Alzheimer’s
2026-10-01
A 2025 Neurotherapeutics study combined live urine-derived stem cell mitochondrial imaging with ResNet-18 classification to identify morphology patterns associated with Alzheimer’s disease and mild cognitive impairment. The approach offers a non-invasive route for studying systemic mitochondrial phenotypes, but larger independent cohorts and functional validation are still needed before clinical use.
-
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-10-01
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide solubilizer for screening poorly soluble hydrophobic compounds, especially molecules containing aromatic or phenyl groups. It is appropriate for pharmaceutical and biochemical research workflows as a drug formulation excipient or solubility aid, but the dossier does not establish universal bioavailability improvement, clinical use, or suitability for unrelated applications.
-
BglII Restriction Endonuclease: Practical Guide
2026-09-30
BglII Restriction Endonuclease (SKU K3010) is designed for rapid cleavage of plasmid DNA, PCR products, and genomic DNA that contain the AGATCT recognition site. Use it for research workflows with a known target sequence and predicted digest pattern; it is not intended for diagnostic or medical applications.
-
HRP Goat Anti-Mouse IgG (H+L) Antibody
2026-09-30
This scenario-driven guide explains how HRP Goat Anti-Mouse IgG (H+L) Antibody, SKU K1221, can strengthen orthogonal protein detection in cell viability, proliferation, and cytotoxicity studies. It covers assay compatibility, optimization, interpretation, storage, and practical vendor-selection criteria.
-
Mithramycin A: A Transcriptional Stress-Test Tool
2026-09-29
Mithramycin A is an anticancer antibiotic that provides a mechanistically distinct way to interrogate G-C-rich transcriptional programs. This article connects its DNA-binding pharmacology with the miR-24-3p/Sp1/PI3K findings in doxorubicin cardiac injury while defining practical assay boundaries.
-
SGI-1027: Translational Leverage in Cancer Epigenetics
2026-09-29
SGI-1027 illustrates how DNA methyltransferase inhibition can move beyond promoter demethylation toward coordinated control of tumor suppressor gene reactivation, lysosomal membrane permeability, apoptosis, and pyroptosis. This thought-leadership perspective translates the evidence into practical study-design guidance for researchers investigating renal cancer and broader cancer epigenetics.
-
Chloramphenicol for Plasmid Selection Workflows
2026-09-28
Chloramphenicol combines tunable selection pressure with a well-defined 50S ribosome mechanism for plasmid maintenance, transformation screening, and engineered transfer assays. This workflow-focused guide connects routine molecular biology selection with recent evidence on carbapenemase-gene mobility while clearly separating plasmid selection from clinical resistance interpretation.
-
Bardoxolone Methyl: Redox Mechanisms & Research Use
2026-09-28
Bardoxolone methyl, also called CDDO methyl ester, is a research compound reported to activate KEAP1–Nrf2 signaling and inhibit NF-kB signaling. This article separates those compound-specific findings from a 2024 study connecting thioredoxin-dependent redox control of ribonucleotide reductase to CHK1 inhibitor sensitivity in lung cancer cells.
-
TaqI Restriction Endonuclease: Practical Guide
2026-09-27
TaqI Restriction Endonuclease (SKU K3053) is a sequence-specific enzyme for rapid digestion of plasmid DNA, PCR products, and genomic DNA at TCG A recognition sites. It supports research workflows such as cloning and DNA analysis, but is not intended for diagnostic or medical use.
-
Mithramycin A Workflows for Cancer Biology Research
2026-09-26
Use Mithramycin A to probe how G-C-rich DNA regulation shapes c-myc expression and myeloid cell phenotypes. This practical guide pairs a cautious dose-and-time pilot with controls that help distinguish transcriptional effects from general cytotoxicity.
-
Diminazene Aceturate: A Context-Dependent Research Probe
2026-09-25
Diminazene Aceturate is best interpreted as a context-dependent research probe, not as a single-purpose mechanistic answer. This article examines how to distinguish its trypanocidal use from ACE2-related findings, assess the strength of the evidence, and design more informative experiments.
-
SGI-1027 Workflows for DNA Methylation Research
2026-09-25
Use SGI-1027 to probe DNMT-dependent methylation and tumor suppressor gene reactivation, while separating growth arrest from actual cell killing. A staged workflow pairs dose and time courses with methylation, expression, protein, and viability readouts so epigenetic effects are not mistaken for general toxicity.
-
CCCP and Mitochondrial Image Assay Interpretation
2026-09-24
CCCP (carbonyl cyanide m-chlorophenyl hydrazine) disrupts the mitochondrial proton gradient, but its effects should not be confused with a direct readout of mitochondrial shape or disease. Learn how to interpret CCCP perturbations alongside deep-learning analysis of urine-derived stem cells and Alzheimer’s disease research.
-
Sodium salicylate for Reliable Cell Assays
2026-09-24
Practical guidance for using Sodium salicylate (SKU B2028) in cell viability and signaling experiments, with attention to assay interpretation, solubility, and controls. The article separates product specifications from workflow recommendations and clarifies what current cross-domain evidence can—and cannot—support.
-
SMAD3 Inhibition Reduces ADAMTS-5 in Early OA
2026-09-23
Xiang et al. report that pharmacological SMAD3 inhibition lowers ADAMTS-5 expression in cell and rat models of early osteoarthritis, alongside increased miRNA-140 expression. The findings suggest a candidate regulatory connection between SMAD3, miRNA-140, and cartilage catabolism, while leaving the precise mediation mechanism and later-stage effects unresolved.